MREO
Price
$0.38
Change
+$0.01 (+2.70%)
Updated
Oct 2 closing price
Capitalization
59.09M
45 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$24.84
Change
+$0.07 (+0.28%)
Updated
Oct 2 closing price
Capitalization
1.9B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MREO vs XNCR

MREO vs XNCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MREO vs. XNCR commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a StrongBuy and XNCR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
MREO vs XNCR: Fundamental Ratings
MREO
XNCR
OUTLOOK RATING
1..100
4372
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4335
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MREO's Valuation (60) in the null industry is in the same range as XNCR (88) in the Biotechnology industry. This means that MREO’s stock grew similarly to XNCR’s over the last 12 months.

MREO's Profit vs Risk Rating (100) in the null industry is in the same range as XNCR (100) in the Biotechnology industry. This means that MREO’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's SMR Rating (97) in the Biotechnology industry is in the same range as MREO (98) in the null industry. This means that XNCR’s stock grew similarly to MREO’s over the last 12 months.

XNCR's Price Growth Rating (35) in the Biotechnology industry is in the same range as MREO (43) in the null industry. This means that XNCR’s stock grew similarly to MREO’s over the last 12 months.

MREO's P/E Growth Rating (2) in the null industry is in the same range as XNCR (5) in the Biotechnology industry. This means that MREO’s stock grew similarly to XNCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MREOXNCR
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (MREO: $0.38 vs. XNCR: $24.84)
Brand notoriety: MREO and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 27% vs. XNCR: 72%
Market capitalization -- MREO: $59.09M vs. XNCR: $1.9B
MREO [@Biotechnology] is valued at $59.09M. XNCR’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green while XNCR’s FA Score has 1 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, MREO is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 2 bullish TA indicator(s).

  • MREO’s TA Score: 5 bullish, 4 bearish.
  • XNCR’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, MREO is a better buy in the short-term than XNCR.

Price Growth

MREO (@Biotechnology) experienced а +2.65% price change this week, while XNCR (@Biotechnology) price change was +4.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.41%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

MREO is expected to report earnings on Nov 17, 2026.

XNCR is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MREO
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PMO9.210.07
+0.77%
Putnam Municipal Opportunities Trust
EMO50.310.37
+0.74%
ClearBridge Energy Midstream Opportunity Fund
TCV32.060.15
+0.47%
Towle Value ETF (TCV)
DRGN31.50-0.43
-1.33%
Themes China Generative Artificial Intelligence ETF (DRGN)
KBDU9.79-0.28
-2.83%
KraneShares 2x Long BIDU Daily ETF (KBDU)

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with RARE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then RARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+3.52%
RARE - MREO
59%
Loosely correlated
+3.19%
TRDA - MREO
40%
Loosely correlated
-5.28%
SYRE - MREO
38%
Loosely correlated
+3.63%
XNCR - MREO
38%
Loosely correlated
+0.28%
NRIX - MREO
38%
Loosely correlated
-1.50%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+0.28%
VCYT - XNCR
52%
Loosely correlated
+3.67%
KURA - XNCR
50%
Loosely correlated
N/A
MLTX - XNCR
49%
Loosely correlated
-0.52%
RCUS - XNCR
48%
Loosely correlated
-3.13%
VIR - XNCR
46%
Loosely correlated
-1.06%
More